• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,157.11 956.43
( 1.26%)
Global Indices
Nasdaq
51,704.04 -29.67
(-0.06%)
Dow Jones
7,389.07 -104.72
(-1.40%)
Hang Seng
69,343.30 -445.08
(-0.64%)
Nikkei 225
10,454.55 16.70
(0.16%)
Forex
USD-INR
94.53 0.21
(0.22%)
EUR-INR
108.18 0.03
(0.03%)
GBP-INR
125.09 0.39
(0.31%)
JPY-INR
0.58 0.00
(0.06%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Astal Laboratories consolidated net profit rises 180.29% in the March 2026 quarter
Jun 01,2026
Net profit of Astal Laboratories rose 180.29% to Rs 7.68 crore in the quarter ended March 2026 as against Rs 2.74 crore during the previous quarter ended March 2025. Sales rose 471.15% to Rs 134.05 crore in the quarter ended March 2026 as against Rs 23.47 crore during the previous quarter ended March 2025.

For the full year,net profit rose 64.73% to Rs 14.71 crore in the year ended March 2026 as against Rs 8.93 crore during the previous year ended March 2025. Sales rose 287.87% to Rs 249.13 crore in the year ended March 2026 as against Rs 64.23 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales134.0523.47 471 249.1364.23 288
OPM %7.6017.81 -8.3419.88 -
PBDT9.203.95 133 18.9612.20 55
PBT8.343.85 117 17.7311.98 48
NP7.682.74 180 14.718.93 65